drugset / Trial / NCT00689780

Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940

NCT00689780

Phase 1 Completed 60 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Phase I, Multi-Centre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940, Including an Interaction Study, After Administration of Oral Multiple Ascending Doses in Adult Subjects with Chronic Low Back Pain

Timeline

Start
2008-03
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1940 Unknown Oral
Subject Midazolam Small molecule Oral

Indications

No indication recorded.